Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen instead of the study record content. The header shows the 403 message and a Home button, indicating restricted access to the page.
    Difference
    20%
    Check dated 2026-09-19T20:53:21.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 has been added to the Contacts and Locations section, while Qiryat Krinitzi, Israel, 52621 has been removed. This reflects a change in the participating sites in Israel.
    Difference
    0.1%
    Check dated 2026-09-12T19:06:37.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Israel study locations were updated: a new site in Qiryat Krinitzi (52621) was added, and Tel Litwinsky (52621) was removed.
    Difference
    0.1%
    Check dated 2026-09-05T19:35:15.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added 2023 ( U.S. NIH Grant/Contract ) to the study's Other Study ID Numbers and updated the revision to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:14:32.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    No textual changes were defined in the data. The page content remains as shown by the input.
    Difference
    0.0%
    Check dated 2026-08-22T14:19:29.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    Plain Language Summary has been removed from the page. This removes a layperson-friendly overview of the study's purpose and design, making it harder for non-experts to quickly understand the trial.
    Difference
    0.1%
    Check dated 2026-08-15T09:09:48.000Z thumbnail image

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.